Jacqueline Emathinger

Jackie Emathinger is a in her 4th MD year of the MD/PhD Program

Current Program Year: MS 4

Current Student, Physiology and Pharmacology Graduate Program, School of Medicine

M.D./Ph.D. Program Students, School of Medicine

Biography

Jackie Emathinger earned her undergraduate degree in biology from San Diego State University. As an undergraduate researcher, she studied molecular mechanisms of myocardial infarction and explored gene therapy techniques to antagonize myocardial dysfunction and cardiac aging.

Jackie joined the MD/PhD program in 2017 with the goal of becoming a physician scientist specializing in cardiovascular physiology and acute organ dysfunction. After completing her didactic medical training, she joined the labs of Drs. Susan Gurley and Michael Hutchens, where she studied the role of ACE2 and the non-canonical renin angiotensin system in hypertension and acute kidney injury. After successfully defending her doctoral dissertation in February 2024, she returned to medical school where her scientific and clinical interests have led her to pursue residency training in anesthesiology.

Her work has been supported by pre-doctoral fellowships from the OHSU Oregon Clinical and Translational Research Institute, the American Heart Association, and the American Society of Nephrology.

Education and training

B.S., San Diego State University 2015

Ph.D., Oregon Health & Science University 2024

Memberships and associations:

  • American Society of Anesthesiologists
  • American Society of Nephrology
  • American College of Physicians

Honors and awards

  • 2025 AOA Medical Honors Society
  • 07/2022-02/2024 American Society of Nephrology KidneyCure Pre-Doctoral Fellowship Award
  • 01/2022-12/2022 American Heart Association Pre-Doctoral Fellowship Award #926639
  • 2022 Best Poster Presentation, OHSU Dept. of Medicine Research Retreat
  • 2022 Kidney STARS (Students and Residents)
  • 2021 Kidney STARS (Students and Residents)
  • 2019 OHSU Forging the Way Award -Oregon Dept. of Justice, Victims of Crimes Act Grantees
  • 2018-2019 OHSU Medical Scientist Training Program T32

Publications

Selected publications

Burfiend KG, Funahashi Y, Su XT, Lackey AE, Hagen MW, Blanche SBJ, Emathinger JM, Hebert JF, McDonough AA, Gurley SB, Nelson JW, Hutchens MP. Kidney cell response to acute cardiorenal and isolated kidney ischemia-reperfusion injury. Physiological Genomics. February 2025; 57(4):266-278. Cited in PubMed; PMID: 39982410.

Hebert JF, Funahashi Y, Emathinger JM, Nickerson MN, Groat T, Andeen NK, Gurley SB, Hutchens MP. Parental recovered acute kidney injury causes prenatal renal dysfunction and fetal growth restriction with sexually dimorphic implications for adult offspring. Frontiers in Physiology. April 2024; 15( N/A):N/A. Cited in PubMed; PMID: 38681142.

Duan XP, Xiao Y, Su XT, Zheng JY, Gurley S, Emathinger J, Yang CL, McCormick J, Ellison DH, Lin DH, Wang WH. Role of Angiotensin II Type 1a Receptor (AT1aR) of Renal Tubules in Regulating Inwardly Rectifying Potassium Channels 4.2 (Kir4.2), Kir4.1, and Epithelial Na+ Channel (ENaC). Hypertension. January 2024; 81(1):126-137. Cited in PubMed; PMID: 37909221.

Nelson JW, Ortiz-Melo DI, Mattocks NK, Emathinger JM, Prescott J, Xu K, Griffiths RC, Wakasaki R, Piehowski PD, Hutchens MP, Coffman TM, Gurley SB. Soluble ACE2 is Filtered into the Urine. Kidney360. August 2022; 3(12):2086-2094. Cited in PubMed; PMID: 36591353.

Emathinger J, Nguyen N, Quijada P, Bers D, Sussman M, Hariharan N. Abstract 12587: Telomere Length Regulates Cellular Fate of Cardiac Progenitor Cells. Circulation Research. November 2015; 132(suppl_3).